Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/γcnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34 + cells

Experimental Hematology

Volumn 31, Issue 9, 2003, Pages 789-797

  Matsumura, Takuya ^a,b   Kametani, Yoshie ^b   Ando, Kiyoshi ^b   Hirano, Yasuyuki ^b   Katano, Ikumi ^b   Ito, Ryoji ^b,c   Shiina, Masashi ^b   Tsukamoto, Hideo ^b   Saito, Yuki ^b   Tokuda, Yutaka ^b   Kato, Shunichi ^b   Ito, Mamoru ^c   Motoyoshi, Kazuo ^a   Habu, Sonoko ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; CD19 ANTIGEN; CD34 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL MATURATION; CELL MOTILITY; CELL TRANSPLANTATION; CONTROLLED STUDY; FETUS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNIZATION; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; NORMAL HUMAN; ONTOGENY; PRIORITY JOURNAL; SERUM; SPLEEN CELL; UMBILICAL CORD BLOOD;

EID: 0042235806     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00193-0     Document Type: Article

References (29)

1. Ueda T., Tsuji K., Yoshino H., et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 105:2000;1013-1021.
2. + cells derived from human fetal liver as compared to fetal bone marrow. Haematologica. 86:2001;1021-1028.
3. + cells from umbilical cord blood as compared to adult sources. Bone Marrow Transplant. 28:2001;163-171.
4. + cord blood cells. J Exp Med. 189:1999;1601-1610.
5. Pflumio F., Izac B., Katz A., Shultz L.D., Vainchenker W., Coulombel L. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood. 88:1996;3731-3740.
6. Larochelle A., Vormoor J., Hanenberg H., et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 2:1996;1329-1337.
7. +-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood. 90:1997;85-96.
8. van der Loo J.C., Hanenberg H., Cooper R.J., Luo F.Y., Lazaridis E.N., Williams D.A. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood. 92:1998;2556-2570.
9. + cord blood cells. Exp Hematol. 30:2002;1036-1043.
10. Hayakawa K., Hardy R.R. Development and function of B-1 cells. Curr Opin Immunol. 12:2000;346-353.
11. Kantor A.B., Herzenberg L.A. Origin of murine B cell lineages. Annu Rev Immunol. 11:1993;501-538.
12. + B cells in the peritoneal cavity. Scand J Immunol. 46:1997;541-545.
13. Kantor A.B., Merrill C.E., Herzenberg L.A., Hillson J.L. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol. 158:1997;1175-1186.
14. Kipps T.J. The CD5 B cell. Adv Immunol. 47:1989;117-185.
15. Kantor A.B., Stall A.M., Adams S., Herzenberg L.A. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci U S A. 89:1992;3320-3324.
16. +B) cells. Int Immunol. 4:1992;243-252.
17. Moretta A., Maccario R., Fagioli F., et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol. 29:2001;371-379.
18. + B lymphoid cells in NOD/SCID mice. Stem Cells. 17:1999;242-252.
19. Ito M., Hiramatsu H., Kobayashi K., et al. NOD/SCID/γ(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 100:2002;3175-3182.
20. + cells in the murine thymic environment. Int Immunol. 14:2002;1113-1124.
21. + cells in nonobese diabetic/Shi-scid, IL-2 receptorγnull mice. J Immunol. 169:2002;204-209.
22. Wardemann H., Boehm T., Dear N., Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med. 195:2002;771-780.
23. Ikawa M., Kominami K., Yoshimura Y., Tanaka K., Nishimune Y., Okabe M. A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP). FEBS Lett. 375:1995;125-128.
24. -/- mice. J Exp Med. 194:2001;1141-1150.
25. Schiemann B., Gommerman J.L., Vora K., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 293:2001;2111-2114.
26. Ansel K.M., Harris R.B., Cyster J.G. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity. 16:2002;67-76.
27. +B) cells. Int Immunol. 4:1992;243-252.
28. Schettino E.W., Chai S.K., Kasaian M.T., Schroeder H.W. Jr., Casali P. VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J Immunol. 158:1997;2477-2489.
29. Rothstein T.L., Kolber D.L. Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J Immunol. 140:1988;2880-2885.